BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 17485767)

  • 1. Consumers' preferences for the communication of risk information in drug advertising.
    Davis JJ
    Health Aff (Millwood); 2007; 26(3):863-70. PubMed ID: 17485767
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FDA direct-to-consumer advertising for prescription drugs: what are consumer preferences and response tendencies?
    Khanfar N; Loudon D; Sircar-Ramsewak F
    Health Mark Q; 2007; 24(1-2):77-91. PubMed ID: 19042521
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Direct-to-consumer advertising and its utility in health care decision making: a consumer perspective.
    Deshpande A; Menon A; Perri M; Zinkhan G
    J Health Commun; 2004; 9(6):499-513. PubMed ID: 15764449
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The attitudes and beliefs of oncology nurse practitioners regarding direct-to-consumer advertising of prescription medications.
    Viale PH; Sanchez Yamamoto D
    Oncol Nurs Forum; 2004 Jul; 31(4):777-83. PubMed ID: 15252431
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Attitude toward direct-to-consumer advertising and drug inquiry intention: the moderating role of perceived knowledge.
    An S
    J Health Commun; 2007 Sep; 12(6):567-80. PubMed ID: 17763053
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Direct-to-consumer advertising (DTCA) for prescription drugs: consumers' attitudes and preferences concerning its regulation in South Korea.
    Suh HS; Lee D; Kim SY; Chee DH; Kang HY
    Health Policy; 2011 Aug; 101(3):260-8. PubMed ID: 21705104
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Age differences in how consumers behave following exposure to DTC advertising.
    DeLorme DE; Huh J; Reid LN
    Health Commun; 2006; 20(3):255-65. PubMed ID: 17137417
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of DTC advertisement content on belief tenacity: a study of appeals and argument types.
    Jalnawala N; Wilkin NE
    Res Social Adm Pharm; 2007 Mar; 3(1):28-46. PubMed ID: 17350556
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Health literacy knowledge among direct-to-consumer pharmaceutical advertising professionals.
    Mackert M
    Health Commun; 2011 Sep; 26(6):525-33. PubMed ID: 21469006
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Riskier than we think? The relationship between risk statement completeness and perceptions of direct to consumer advertised prescription drugs.
    Davis JJ
    J Health Commun; 2000; 5(4):349-69. PubMed ID: 11191018
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ensuring that consumers receive appropriate information from drug ads: what is the FDA's role?
    Waxman HA
    Health Aff (Millwood); 2004; Suppl Web Exclusives():W4-256-8. PubMed ID: 15452002
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of qualifying language on perceptions of drug appeal, drug experience, and estimates of side-effect incidence in DTC advertising.
    Davis J
    J Health Commun; 2007; 12(7):607-22. PubMed ID: 17934939
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Direct-to-consumer ads can influence behavior. Advertising increases consumer knowledge and prescription drug requests.
    Peyrot M; Alperstein NM; Van Doren D; Poli LG
    Mark Health Serv; 1998; 18(2):26-32. PubMed ID: 10180332
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Do ads really drive pharmaceutical sales? The true effects of DTC advertising remain a mystery.
    Findlay S
    Mark Health Serv; 2002; 22(1):20-5. PubMed ID: 11881540
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Drug advertising--users want information. Report of telephone survey conducted by North-Rhine Westphalia Public Health Service on the topic of drug advertising and drug information for users].
    Puteanus U
    Gesundheitswesen; 2000 Oct; 62(10):516-24. PubMed ID: 11103563
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Benefit and risk information in prescription drug advertising: review of empirical studies and marketing implications.
    Kopp SW; Bang HK
    Health Mark Q; 2000; 17(3):39-56. PubMed ID: 11010219
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An assessment of direct-to-consumer advertising of prescription drugs.
    Calfee JE
    Clin Pharmacol Ther; 2007 Oct; 82(4):357-60. PubMed ID: 17851572
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The economics of direct-to-consumer advertising of prescription-only drugs: prescribed to improve consumer welfare?
    Morgan S; Mintzes B; Barer M
    J Health Serv Res Policy; 2003 Oct; 8(4):237-44. PubMed ID: 14596759
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Direct-to-consumer advertising skepticism and the use and perceived usefulness of prescription drug information sources.
    DeLorme DE; Huh J; Reid LN
    Health Mark Q; 2009; 26(4):293-314. PubMed ID: 19916096
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Which prescription for the illegible and unreadable DTC (direct-to-consumer) brief summary--major surgery or euthanasia?
    Hochhauser M
    Manag Care Q; 2002; 10(3):6-10. PubMed ID: 12476659
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.